NeuroOne Medical Technologies Corporation
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $6.6M | $1.5M | $5.3M | $8.2M | $6.9M | $4.0M | $260.7K | $13.3K |
| Accounts Receivable | $1.3M | $176.6K | — | $33.2K | $48.3K | — | — | — |
| Inventory | $2.2M | $2.6M | $1.7M | $704.5K | $98.3K | — | — | — |
| Total Current Assets | $10.2M | $4.6M | $7.3M | $12.2M | $7.3M | $4.2M | $301.8K | $18.6K |
| Property, Plant & Equipment | $259.2K | $416.8K | $525.8K | $353.6K | $223.3K | $166.0K | $52.0K | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $44.9K | $67.3K | $89.6K | $111.9K | $134.2K | $156.5K | $178.8K | $200.1K |
| Total Assets | $10.8M | $5.4M | $8.1M | $12.8M | $7.9M | $4.8M | $532.6K | $218.7K |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $1.0M | $685.1K | $927.7K | $528.8K | $762.5K | $1.2M | $221.2K |
| Total Current Liabilities | $2.3M | $2.2M | $1.8M | $3.1M | $1.2M | $2.4M | $1.8M | $3.8M |
| Long-Term Debt | — | — | $55.3K | $119.6K | $202.9K | $254.3K | — | — |
| Total Liabilities | $3.7M | $4.5M | $1.8M | $3.2M | $1.4M | $2.7M | $1.8M | $4.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-78.6M | $-75.0M | $-62.7M | $-50.8M | $-40.8M | $-30.9M | $-17.2M | $-10.5M |
| Total Stockholders' Equity | $7.1M | $822.0K | $6.2M | $9.6M | $6.6M | $2.1M | $-1.2M | $-4.4M |